Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

NCT00770913 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT00770913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2008
Completion date
March 31, 2010
Enrollment
337 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

refractory reflux esophagitis